• Obstetrics & gynecology science
• /
• 제61권6호
• /
• pp.669-674
• /
• 2018

Objective This study aimed to develop a nomogram that predicts ongoing pregnancy after in vitro fertilization and embryo transfer (IVF-ET) using patient age and serum hormonal markers. Methods A total of 284 IVF-ET cycles were retrospectively analyzed. At 14 days post-oocyte pick-up (OPU), the serum human chorionic gonadotropin (HCG) and progesterone levels were measured. The main predicted outcome was ongoing pregnancy. Results Patient age and serum of HCG and progesterone levels at 14 days post-OPU were good predictors of ongoing pregnancy. The cut-off value and area under the curve (AUC) (95% confidence interval) were 36.5 years and 0.666 (0.599-0.733), respectively, for patient age; 67.8 mIU/mL and 0.969 (0.951-0.987), respectively, for serum HCG level; and 29.8 ng/mL and 0.883 (0.840-0.925), respectively, for serum progesterone level. When the prediction model was constructed using these three parameters, the addition of serum progesterone level to the prediction model did not increase its overall predictability. Furthermore, a high linear co-relationship was found between serum HCG and progesterone levels. Therefore, we developed a new nomogram using patient age and HCG serum level only. The AUC of the newly developed nomogram for predicting ongoing pregnancy after IVF-ET cycles using patient age and serum HCG level was as high as 0.975. Conclusion We showed that ongoing pregnancy may be predicted using only patient age and HCG serum level. Our nomogram could help clinicians and patients predict ongoing pregnancy after IVF-ET if the serum JCG level was ${\geq}5IU/L$ at 14 days post-OPU.

• 가정∙방문간호학회지
• /
• 제30권1호
• /
• pp.48-58
• /
• 2023

Purpose: The purpose of this study was to construct a nomogram for predicting difficulty in peripheral intravenous cannulation (DPIVC) for adult inpatients. Methods: This study conducted a secondary analysis of data from the intravenous cannulation cohort by intravenous specialist nurses at a tertiary hospital in Seoul. Overall, 504 patients were included; of these, 166 (32.9%) patients with failed cannulation in the first intravenous cannulation attempt were included in the case group, while the remaining 338 patients were included in the control group. The nomogram was built with the identified risk factors using a multiple logistic regression analysis. The model performance was analyzed using the Hosmer-Lemeshow test, area under the curve (AUC), and calibration plot. Results: Five factors, including vein diameter, vein visibility, chronic kidney disease, diabetes, and chemotherapy, were risk factors of DPIVC. The nomogram showed good discrimination with an AUC of 0.81 (95% confidence interval: 0.80-0.82) by the sample data and 0.79 (95% confidence interval: 0.74-0.84) by bootstrapping validation. The Hosmer-Lemeshow goodness-of-fit test showed a p-value of 0.694, and the calibration curve of the nomogram showed high coherence between the predicted and actual probabilities of DPIVC. Conclusion: This nomogram can be used in clinical practice by nurses to predict DPIVC probability. Future studies are required, including those on factors possibly affecting intravenous cannulation.

• Clinical and Experimental Pediatrics
• /
• 제51권1호
• /
• pp.26-32
• /
• 2008

목 적 : 1998년과 2005년 신체발육표준 제정사업 자료를 이용하여 2007년 소아청소년 성장곡선의 개발과정에서에 이용된 성장곡선 및 혈압분포 개발 방법론을 제시하고자 하였다. 방 법 : 성장곡선은 1998년과 2005년 자료를 이용해서 각 백분위수의 성장곡선 모형을 추정하고 LMS를 방법을 이용하여 최종 성장곡선을 생산하였다. 연령과 신장별 혈압 성장곡선은 2005년 자료를 이용하여 남녀별로 고정효과 회귀모형을 적용하여 산출하였다. 결 과 : 2007 소아청소년 성장곡선 및 혈압분포 표를 제시할 수 있었다. 결 론 : 2007년 성장곡선과 혈압분포 표는 현재 가용한 자료와 최신의 통계적 방법을 최대한 활용한 국내 최초의 결과로서 향후 지속적인 발전을 위한 논의와 연구가 필요하다.

• 한국멀티미디어학회논문지
• /
• 제13권5호
• /
• pp.722-729
• /
• 2010

예측 문제를 해결하기 위한 데이타마이닝 기법은 다양한 분야에서 주목받고 있다. 이것에 대한 한 예로 컴퓨터-기반의 질병의 예측 혹은 진단은 CDSS(Clinical Decision support System)에서 가장 중요한 요소이기도 하다. 이러한 예측 문제를 해결하기 위해서 RBF커널 같은 비선형 커널을 사용한 SVM이 가장 널리 사용되고 있는데, 이는 비선형 SVM이 어떠한 다른 분류기법보다 정확한 성능을 보이기 때문이다. 하지만 비선형 SVM을 사용한 경우에는 모델내부를 시각화하는 일이 어려워서 예측결과에 대한 직관적인 이해가 힘들고, 의학 전문가들은 이러한 비선형 SVM의 사용을 기피하고 있는 실정이다. Nomogram은 SVM을 시각화하기 위해 제안된 기법이다. 하지만 이는 선형 SVM의 경우에만 사용이 가능하고. 이 문제를 해결하기 위해서 LRBF 커널이 제안된 바 있다. LRBF 커널은 기존의 RBF 커널을 사용한 SVM과 대등한 결과를 보이면서도 예측결과의 선형적 분석도 가능하게 한다. 본 논문에서는 노모그램(Nomogram)과 LRBF 커널을 사용한 SVM이 통합되어 있는 예측 툴 VRIFA를 제안한다. 이 툴은 사용자와 상호작용하며 비선형 SVM 모델의 내부구조를 데이타의 각 속성별로 보여주는 방법으로 사용자가 예측결과를 직관적으로 이해하도록 도와준다. VRIFA는 Nomogram기반의 피쳐선택(feature selection) 기능도 포함하고 있는데, 이 기능은 예측결과에 부정적인 영향을 끼치거나 중복된 연관성을 보이는 속성을 제거함으로써 모델의 정확도를 높이는 데 기여한다. 그리고 데이터에 포함된 클래스의 비율이 한 쪽으로 치우쳐져 있는 경우에는 ROC 곡선 넓이(AUC)를 예측결과를 평가하기 위한 측도로 사용할 수 있다. 이 툴은 컴퓨터-기반의 질병 예측 혹은 질병의 위험 요소 분석에 대해 연구하는 연구자들에게 유용하게 사용될 것으로 전망하는 바이다.

• Radiation Oncology Journal
• /
• 제36권2호
• /
• pp.139-146
• /
• 2018

Purpose: IBTR! 2.0 nomogram is web-based nomogram that predicts ipsilateral breast tumor recurrence (IBTR). We aimed to validate the IBTR! 2.0 using an external data set. Materials and Methods: The cohort consisted of 2,206 patients, who received breast conserving surgery and radiation therapy from 1992 to 2012 at our institution, where wide surgical excision is been routinely performed. Discrimination and calibration were used for assessing model performance. Patients with predicted 10-year IBTR risk based on an IBTR! 2.0 nomogram score of <3%, 3%-5%, 5%-10%, and >10% were assigned to groups 1, 2, 3, and 4, respectively. We also plotted calibration values to observe the actual IBTR rate against the nomogram-derived 10-year IBTR probabilities. Results: The median follow-up period was 73 months (range, 6 to 277 months). The area under the receiver operating characteristic curve was 0.607, showing poor accordance between the estimated and observed recurrence rate. Calibration plot confirmed that the IBTR! 2.0 nomogram predicted the 10-year IBTR risk higher than the observed IBTR rates in all groups. High discrepancies between nomogram IBTR predictions and observed IBTR rates were observed in overall risk groups. Compared with the original development dataset, our patients had fewer high grade tumors, less margin positivity, and less lymphovascular invasion, and more use of modern systemic therapies. Conclusions: IBTR! 2.0 nomogram seems to have the moderate discriminative ability with a tendency to over-estimating risk rate. Continued efforts are needed to ensure external applicability of published nomograms by validating the program using an external patient population.

• Journal of Breast Disease
• /
• 제6권2호
• /
• pp.52-59
• /
• 2018

Purpose: This study aimed to determine whether clinicopathological factors are potentially associated with successful breast-conserving surgery (BCS) after neoadjuvant chemotherapy (NAC) and develop a nomogram for predicting successful BCS candidates, focusing on those who are diagnosed with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative tumors during the pre-NAC period. Methods: The training cohort included 239 patients with an HR-positive, HER2-negative tumor (${\geq}3cm$), and all of these patients had received NAC. Patients were excluded if they met any of the following criteria: diffuse, suspicious, malignant microcalcification (extent >4 cm); multicentric or multifocal breast cancer; inflammatory breast cancer; distant metastases at the time of diagnosis; excisional biopsy prior to NAC; and bilateral breast cancer. Multivariate logistic regression analysis was conducted to evaluate the possible predictors of BCS eligibility after NAC, and the regression model was used to develop the predicting nomogram. This nomogram was built using the training cohort (n=239) and was later validated with an independent validation cohort (n=123). Results: Small tumor size (p<0.001) at initial diagnosis, long distance from the nipple (p=0.002), high body mass index (p=0.001), and weak positivity for progesterone receptor (p=0.037) were found to be four independent predictors of an increased probability of BCS after NAC; further, these variables were used as covariates in developing the nomogram. For the training and validation cohorts, the areas under the receiver operating characteristic curve were 0.833 and 0.786, respectively; these values demonstrate the potential predictive power of this nomogram. Conclusion: This study established a new nomogram to predict successful BCS in patients with HR-positive, HER2-negative breast cancer. Given that chemotherapy is an option with unreliable outcomes for this subtype, this nomogram may be used to select patients for NAC followed by successful BCS.

• Journal of Gastric Cancer
• /
• 제23권2호
• /
• pp.355-364
• /
• 2023

Background: There are no clear guidelines to determine whether to perform D1 or D1+ lymph node dissection in early gastric cancer (EGC). This study aimed to develop a nomogram for estimating the risk of extraperigastric lymph node metastasis (LNM). Materials and Methods: Between 2009 and 2019, a total of 4,482 patients with pathologically confirmed T1 disease at 6 affiliated hospitals were included in this study. The basic clinicopathological characteristics of the positive and negative extraperigastric LNM groups were compared. The possible risk factors were evaluated using univariate and multivariate analyses. Based on these results, a risk prediction model was developed. A nomogram predicting extraperigastric LNM was used for internal validation. Results: Multivariate analyses showed that tumor size (cut-off value 3.0 cm, odds ratio [OR]=1.886, P=0.030), tumor depth (OR=1.853 for tumors with sm2 and sm3 invasion, P=0.010), cross-sectional location (OR=0.490 for tumors located on the greater curvature, P=0.0303), differentiation (OR=0.584 for differentiated tumors, P=0.0070), and lymphovascular invasion (OR=11.125, P<0.001) are possible risk factors for extraperigastric LNM. An equation for estimating the risk of extraperigastric LNM was derived from these risk factors. The equation was internally validated by comparing the actual metastatic rate with the predicted rate, which showed good agreement. Conclusions: A nomogram for estimating the risk of extraperigastric LNM in EGC was successfully developed. Although there are some limitations to applying this model because it was developed based on pathological data, it can be optimally adapted for patients who require curative gastrectomy after endoscopic submucosal dissection.